Prognosis of immunotherapy for non-small cell lung cancer with <i>CDKN2A</i> loss of function.

Publication Year: 2024

DOI:
10.21037/jtd-23-1017

PMCID:
PMC10894420

PMID:
38410565

Journal Information

Full Title: J Thorac Dis

Abbreviation: J Thorac Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Respiratory System

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1017/coif). Y.J. reports funding by the Natural Science Foundation of Hubei Province, China (No. 2021CFB407). The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: The study was supported by the Natural Science Foundation of Hubei Province, China ( No. 2021CFB407 to Y.J.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025